Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05202834 · ClinicalTrials.gov registry record
Evaluation of the UltraClear Laser Workstation for Skin Treatment - Histology Study of Laser Ablation on Human Skin
A clinical trial, sponsored by FA Corporation.
- Completed
- Registry status
- 3
- Enrollment target
NCT05202834: Completed study, sponsored by FA Corporation.
NCT05202834 is a clinical trial that has completed, run by FA Corporation. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05202834 has completed, sponsored by FA Corporation.
- COMPLETED
- Registry status
- 3 participants
- Enrollment target
Study Summary
Evaluation of the UltraClear Laser Workstation for Skin Treatment - Histology Study of Laser Ablation on human skin
Primary Outcome
Histological specimens microscope ready slides
Interventions
- DEVICE UltraClear
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2021-07-15 |
| Est. Completion | 2021-11-10 |
What the finished NCT05202834 record still lists
NCT05202834 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which UltraClear is the first listed.
NCT05202834 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05202834 about?
NCT05202834 is a clinical study titled "Evaluation of the UltraClear Laser Workstation for Skin Treatment - Histology Study of Laser Ablation on Human Skin". Evaluation of the UltraClear Laser Workstation for Skin Treatment - Histology Study of Laser Ablation on human skin
What is the current status of trial NCT05202834?
This trial is currently completed. The enrollment target is 3 participants. The study started on 2021-07-15. Estimated completion is 2021-11-10.
What interventions are being tested in trial NCT05202834?
The interventions under investigation include: UltraClear (DEVICE).
Who is sponsoring clinical trial NCT05202834?
This trial is sponsored by FA Corporation, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI